Zuranolone, a GABAA receptor positive allosteric modulator: safety from SKYLARK, a phase 3 placebo-controlled study in adults with postpartum depression

Read full text
Authors: L. Shirikjian, J. A. Ramos-Quiroga, K. LaGuerre, T. Vera, F. Forrestal, S. Levin, J.F. Joseph
Cited by: 0

Fields of Study & Subjects

Tryptophan and brain disorders Neuroscience and Neuropharmacology Research Neuroendocrine regulation and behavior

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
106039–106039
Publication date
1 January 2026
Language
EN